About Safeplus International Holdings

Safeplus Intl Hldgs Ltd, a technology development and holding company, focuses on the creation and sale of technologies and medical devices, including MRI compatible implants and devices, and circulatory support systems. Myotech Circulatory Support System (CSS) The company is focused on developing a circulatory support system, the Myotech CSS. The Myotech CSS is a one-of-a-kind mechanical circulatory support system that’s based on a family of technologies known as Direct Mechanical Ventricular Actuation (DMVA). The Myotech CSS is aimed at the treatment of acute heart failure patients. MRI Related Technologies The company’s technologies for MRI safety and image compatibility apply to a segment of the medical device marketplace. It has developed solutions to the problems of both MRI safety and MRI image compatibility of medical devices and implants. The company focuses on partnering its technologies, including the Myotech CSS and some of its other early stage technologies, such as pulsewidth modulation to increase the life of implantable pacemakers and neurostimulators. Biophan’s subsidiary, Biophan Europe, focuses on further developing its MRI image compatibility technologies. Competition The company’s competitors include Abiomed, Thoratec, and World Heart in the ventricular assist device market; and Datascope in the intraortic balloon pump market. It also competes with PPA Technologies AG, in Germany, which is in the process of developing a device that provides non-blood contacting support for acute heart failure. History The company was formerly known as Biophan Technologies, Inc. and changed its name to Safeplus International Holdings Limited in September 2020. The company was founded in 1963.